en

PRODUCT DETAIL

Dezmopresín Teva 240 mikrogramov sublingválne tablety

Code 4761E
MA number 56/0250/23-S
Product Form: tbl slg 30x240 µg (fľ.HDPE)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU)
ATC:
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
H01B POSTERIOR PITUITARY LOBE HORMONES
H01BA Vasopressin and analogues
H01BA02 Desmopressin
Shelf life: 30
Route of admin.: Sublingual use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 25.10.2023
Validity: 25.10.2028
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric contraindication: Yes
Pediatric warnings: Yes
SPC: SPC_Dezmopresín Teva_10.2023.pdf  
PIL: PIL_Dezmopresín Teva_10.2023.pdf  
Safety feature Yes
Data update: 14.11.2023
eu-flag.png sk-flag.png